2022 - Research.com Medicine in Belgium Leader Award
Jean-Yves Reginster mainly investigates Osteoporosis, Internal medicine, Surgery, Physical therapy and Placebo. Jean-Yves Reginster works mostly in the field of Osteoporosis, limiting it down to topics relating to Bone remodeling and, in certain cases, N-terminal telopeptide. Jean-Yves Reginster has included themes like Osteoarthritis and Endocrinology in his Internal medicine study.
His study looks at the relationship between Surgery and topics such as Bisphosphonate, which overlap with Regimen. His Physical therapy research integrates issues from Evidence-based medicine, MEDLINE, Quality of life, Quality of life and Intensive care medicine. His Placebo study combines topics in areas such as Gastroenterology, Incidence, Chemotherapy and Confidence interval.
Jean-Yves Reginster spends much of his time researching Internal medicine, Osteoporosis, Physical therapy, Osteoarthritis and Endocrinology. Internal medicine is frequently linked to Placebo in his study. His research in Osteoporosis intersects with topics in Surgery, Bone remodeling and Intensive care medicine.
His Physical therapy research is multidisciplinary, incorporating perspectives in Alternative medicine, Hip fracture and Quality of life. His study in the field of Glucosamine Sulfate also crosses realms of In patient. His work carried out in the field of Bone mineral brings together such families of science as Femoral neck and Urology.
His primary areas of investigation include Internal medicine, Osteoporosis, Osteoarthritis, Sarcopenia and Gerontology. Internal medicine is closely attributed to Placebo in his work. He studies Osteoporosis, focusing on Bone mineral in particular.
His study on Osteoarthritis also encompasses disciplines like
Physical therapy together with Reliability,
MEDLINE that intertwine with fields like Randomized controlled trial. His Sarcopenia study also includes
Quality of life and related Construct validity,
Prospective cohort study and related Lean body mass. While the research belongs to areas of Gerontology, he spends his time largely on the problem of Cohort, intersecting his research to questions surrounding Malnutrition.
His scientific interests lie mostly in Internal medicine, Sarcopenia, Osteoporosis, Osteoarthritis and Physical therapy. Internal medicine and Placebo are frequently intertwined in his study. His Osteoporosis research is mostly focused on the topic FRAX.
His Osteoarthritis research also works with subjects such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
Robert M. Neer;Claude D. Arnaud;Jose R. Zanchetta;Richard Prince.
The New England Journal of Medicine (2001)
Effect of Risedronate on the Risk of Hip Fracture in Elderly Women
Michael R. McClung;Piet Geusens;Paul D. Miller;Hartmut Zippel.
The New England Journal of Medicine (2001)
The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis
Pierre J. Meunier;Christian Roux;Ego Seeman;Sergio Ortolani.
The New England Journal of Medicine (2004)
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
Jean-Yves Reginster;H. W. Minne;O. H. Sorensen;M. Hooper.
Osteoporosis International (2000)
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
Jean Yves Reginster;Jean Yves Reginster;Rita Deroisy;Lucio C Rovati;Richard L Lee.
The Lancet (2001)
Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature.
Olivier Ethgen;Olivier Bruyère;Florent Richy;Charles Dardennes.
Journal of Bone and Joint Surgery, American Volume (2004)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
John A. Kanis;Eugene V. McCloskey;Helena Johansson;Cyrus Cooper.
Osteoporosis International (2008)
Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study
J Y. Reginster;E Seeman;M C. De Vernejoul;S Adami.
The Journal of Clinical Endocrinology and Metabolism (2005)
Osteoporosis: a still increasing prevalence.
Jean-Yves Reginster;Nansa Burlet.
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung;Andreas Grauer;Steven Boonen;Michael A. Bolognese.
The New England Journal of Medicine (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: